Status:
ACTIVE_NOT_RECRUITING
Optimizing Detection and Prediction of Changes in Cognitive Function in Multiple Sclerosis (MS)
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Wayne State University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
The researchers will use technology-assisted ambulatory assessment techniques to examine cognitive dysfunction in people with Multiple Sclerosis (MS). The researchers will determine if ambulatory ass...
Eligibility Criteria
Inclusion
- Are able to fluently converse and read in English.
- Multiple Sclerosis (MS) diagnosis (confirmed from neurologist, all relapsing and progressive subtypes included)
- Ambulate either independently or with the use of a cane or walker (or similar device) for at least 50% of the time at baseline
Exclusion
- MS relapse within the past 30 days (may become eligible after 30 days; criteria used at T1, T2, and T3).
- Inability to use study data collection tools (i.e., ActiGraph wrist-worn activity watch, smart phone app).
Key Trial Info
Start Date :
May 24 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2027
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05252195
Start Date
May 24 2022
End Date
March 1 2027
Last Update
April 27 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109
2
Wayne State University
Detroit, Michigan, United States, 48202
3
University of Washington
Seattle, Washington, United States, 98195